Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead offloads a PhII-ready addiction therapy to an upstart which knows this drug well
Endpoints
Sat, 02/18/17 - 02:21 pm
Gilead Sciences
addiction
GS-6637
CV Therapeutics
Gilead challenges GSK with strong HIV drug data
Yahoo/Reuters
Tue, 02/14/17 - 09:28 am
Gilead Sciences
GSK
HIV
bictegravir
Dolutegravir
Is Gilead Sciences Getting Ready for a Massive Acquisition?
Motley Fool
Mon, 02/13/17 - 10:12 am
Gilead Sciences
M&A
Gilead to use dating sites, Tumblr, and Snapchat in Truvada strategy
Medical Marketing and Media
Thu, 02/9/17 - 11:16 am
Gilead Sciences
social media
Truvada
HIV
GlaxoSmithKline and Gilead to face off at HIV meeting next week
Yahoo/Reuters
Thu, 02/9/17 - 09:44 am
GSK
Gilead Sciences
HIV
bictegravir
Dolutegravir
Gilead cured hepatitis C. That’s become its biggest problem
Marketwatch
Wed, 02/8/17 - 09:27 pm
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead’s Biggest Blockbusters Are Fading Fast, Biotech Warns
Bloomberg
Wed, 02/8/17 - 09:21 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead 2017 hepatitis C sales forecast disappoints, shares drop
Yahoo/Reuters
Tue, 02/7/17 - 06:31 pm
Gilead Sciences
earnings
3 Crucial Questions Gilead Sciences Should Answer Tuesday
Motley Fool
Sun, 02/5/17 - 12:47 pm
Gilead Sciences
earnings
3 Critical Things to Watch in Gilead Sciences' Q4 Results
Motley Fool
Wed, 02/1/17 - 09:47 am
Gilead Sciences
earnings
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
BioPharma Dive
Sat, 01/28/17 - 02:39 pm
Merck
Sanofi
Eli Lilly
Pfizer
Roche
AstraZeneca
Gilead Sciences
Allergan
GSK
3 Companies Putting the Squeeze on Bristol-Myers Squibb
Motley Fool
Sat, 01/28/17 - 02:27 pm
Bristol-Myers Squibb
Merck
Roche
Gilead Sciences
Forget Incyte: Gilead Sciences Would Be Better Off Buying This Company
Motley Fool
Wed, 01/25/17 - 09:53 am
Gilead Sciences
Incyte
M&A
Galapagos
Has Gilead Sciences' Cash Cow Finally Hit Bottom?
Motley Fool
Mon, 01/23/17 - 10:26 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead’s Vemlidy Hep B Drug Approved In EU
Investopedia
Sun, 01/15/17 - 11:16 am
Gilead Sciences
hepatitis B
Vemlidy
Europe
Gilead Sciences: The M&A Question
Barron's
Fri, 01/13/17 - 09:34 am
M&A
Gilead Sciences
Pharma industry needs to be more transparent on drug pricing, Gilead CEO says
CNBC
Wed, 01/11/17 - 10:03 am
Pharma CEOs
drug pricing
Gilead Sciences
John Milligan
JPMHC 2017
3 Takeover Candidates in the Drug Space
TheStreet.com
Mon, 01/9/17 - 09:45 am
M&A
Gilead Sciences
JNJ
Pfizer
Merck
Novartis
Eli Lilly
Bristol-Myers Squibb
Biogen
Biotech Investing: 3 Bold Predictions for 2017
Motley Fool
Fri, 01/6/17 - 09:47 am
biotech
Incyte
Biogen
Biomarin
Gilead Sciences
Illumina
Valeant Is A Strong Acquisition Target
Seeking Alpha
Thu, 01/5/17 - 09:36 am
Valeant Pharmaceuticals
M&A
Gilead Sciences
Pfizer
Amgen
Pages
« first
‹ previous
…
41
42
43
44
45
46
47
48
49
…
next ›
last »